Αποτελέσματα Αναζήτησης
Recommended therapy algorithm for the treatment of chronic urticaria. wks weeks, mo months, CIndU chronic inducible urticaria. A second-generation non-sedating H1 antihistamine is the first treatment of choice.
1 Οκτ 2024 · Treatment for chronic hives often starts with nonprescription anti-itch medicines, called antihistamines. If these don't help, your healthcare professional might suggest that you try one or more prescription-strength medicines.
1 Ιουν 2017 · The mainstay of treatment is avoidance of triggers, if identified. The first-line pharmacotherapy is second-generation H 1 antihistamines, which can be titrated to greater than standard...
The main treatment for chronic urticaria in adults and children is with an oral second-generation H 1-antihistamines such as cetirizine or loratidine. If the standard dose (eg, 10 mg for cetirizine) is not effective, the dose can be increased fourfold (eg, 40 mg cetirizine daily).
27 Ιουλ 2024 · Treatments that prevent, delay, or slow the progression of chronic urticaria and induce disease remission are needed. This Therapeutics article describes existing unmet medical needs in personalised chronic urticaria treatment and discusses how emerging drugs can address them.
8 Αυγ 2022 · The recommendations for the use of first-line treatment (antihistamine), second-line treatment (omalizumab), and third-line treatment (cyclosporine) now include guidance on updosing and duration (Fig 3, A and B).
Antihistamines and omalizumab are the mainstay therapies of CU. Additional treatment options are needed. Here, we review the off and beyond label use of licensed drugs, novel treatments that are currently under development, and promising new targets.
